Cardiovascular Diseases Clinical Trial
To determine the clinical course of coronary artery disease among Blacks receiving medical care for symptomatic heart diseases.
BACKGROUND:
The Black population has age-specific all causes mortality rates among adults which are up
to 3.5 times higher than for whites. There remains a pressing need to improve detection and
treatment of coronary artery disease among Blacks in an attempt to reduce these unfavorable
racial differentials. Also, many fundamental advances in our understanding of
atherosclerosis have come from the study of geographic pathology - the epidemiologic
comparisons of population groups with widely varying distributions of risk factors. Two
prominent features of the epidemiology of coronary artery disease among United States Blacks
which are fertile grounds for such comparative studies are the high prevalence of
hypertension and the increased susceptibility of Black women to this disease. Knowledge
gained from these studies can potentially be applied to coronary artery disease in all human
population groups, as has been done with work among the Masai, Seventh-Day Adventists, and
other groups.
DESIGN NARRATIVE:
In this longitudinal study, patients were recruited from the adult Emergency Service of Cook
County Hospital. Key end-points included: case fatality rates from acute events; long-term
survival rates; sudden versus non-sudden death rates; occurrence of first myocardial
infarction among patients with new onset angina; functional recovery after myocardial
infarction and coronary artery bypass graft. Baseline data were collected in all groups and
include: age, sex, education, weight, height, medical history, hyperlipidemia, alcohol and
cigarette use, and medications. Both two-dimensional and M-mode echocardiograms were
obtained and an exercise test performed. At the time of cardiac catheterization fasting
blood samples were drawn for lipid analysis. Bi-plane ventriculography and cineangiography
were performed. After discharge, patients returned to the clinic at three-month intervals
for up to two years. Analyses were conducted on left ventricular hypertrophy and
socioeconomic status as predictors of mortality. The two control groups permitted
comparisons of baseline findings and end-points. One hundred and fifty patients from each of
the control groups were followed long-term, primarily through surveillance of government
vital status records. The study provided data on survival rates, incidence of new events,
and mode of death, the roles of sex differences and hypertension in coronary artery disease,
and the efficacy of coronary artery bypass surgery.
The study was renewed in FY 1993 to address a series of major questions related to the
clinical epidemiology of coronary artery disease among Black women and to continue the on
going study involving 2,806 Black men and women who had been enrolled in a hospital-based
registry. An examination of the survival patterns and related risk factors in the cohort of
1,559 Black women was the primary focus of this project.
The study was renewed in 1996 to continue to follow the original cohort to examine the
interaction of left ventricular hypertrophy (LVH) and mortality risk in the subgroup of
patients with coronary heart disease, to investigate further the impact of left ventricular
geometry on survival, and to define the prognostic significance of obesity. Also to enroll a
new clinical cohort of 5,600 patients, approximately equally divided between Blacks and
whites, from Louisiana State University (LSU) Medical Center. The survival patterns of these
groups are compared directly, and the contribution of LVH to the Black:white differential
estimated. The new cohort serves as a validation sample for the hypotheses derived from the
original cohort.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|